Annie M. Hassell

1.2k total citations
5 papers, 456 citations indexed

About

Annie M. Hassell is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Annie M. Hassell has authored 5 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 2 papers in Oncology. Recurrent topics in Annie M. Hassell's work include Neuropeptides and Animal Physiology (2 papers), Peptidase Inhibition and Analysis (2 papers) and Endoplasmic Reticulum Stress and Disease (1 paper). Annie M. Hassell is often cited by papers focused on Neuropeptides and Animal Physiology (2 papers), Peptidase Inhibition and Analysis (2 papers) and Endoplasmic Reticulum Stress and Disease (1 paper). Annie M. Hassell collaborates with scholars based in United States, Canada and Netherlands. Annie M. Hassell's co-authors include Lisa M. Shewchuk, Justin A. Caravella, Millard H. Lambert, Bruce Wisely, David J. Mangelsdorf, Timothy M. Willson, K.D. Baker, Carl S. Thummel, Makoto Makishima and Jeffrey Reinking and has published in prestigious journals such as Cell, PLoS ONE and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Annie M. Hassell

5 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annie M. Hassell United States	5	230	183	125	82	77	5	456
Diane Tabarini United States	8	438 1.9×	167 0.9×	92 0.7×	97 1.2×	68 0.9×	10	749
Pierre Poussin‐Courmontagne France	10	400 1.7×	47 0.3×	79 0.6×	63 0.8×	106 1.4×	15	549
Iron F. De Paula Brazil	8	221 1.0×	91 0.5×	26 0.2×	61 0.7×	43 0.6×	9	360
Utako Kato Japan	8	515 2.2×	48 0.3×	267 2.1×	46 0.6×	47 0.6×	11	667
Mohammed Mahidur Rahman United States	6	323 1.4×	47 0.3×	65 0.5×	92 1.1×	43 0.6×	9	538
John P. Wing United States	6	881 3.8×	87 0.5×	183 1.5×	182 2.2×	59 0.8×	6	1.0k
Angela Flagiello Italy	11	249 1.1×	59 0.3×	40 0.3×	34 0.4×	34 0.4×	17	501
Moira V. Ellis United Kingdom	10	435 1.9×	34 0.2×	216 1.7×	35 0.4×	55 0.7×	16	606
Angela Hach United States	9	864 3.8×	45 0.2×	290 2.3×	84 1.0×	51 0.7×	9	988

Countries citing papers authored by Annie M. Hassell

Since Specialization

Citations

This map shows the geographic impact of Annie M. Hassell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie M. Hassell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie M. Hassell more than expected).

Fields of papers citing papers by Annie M. Hassell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie M. Hassell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie M. Hassell. The network helps show where Annie M. Hassell may publish in the future.

Co-authorship network of co-authors of Annie M. Hassell

This figure shows the co-authorship network connecting the top 25 collaborators of Annie M. Hassell. A scholar is included among the top collaborators of Annie M. Hassell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie M. Hassell. Annie M. Hassell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Axten, Jeffrey M., Stuart P. Romeril, Arthur Y. L. Shu, et al.. (2013). Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development. ACS Medicinal Chemistry Letters. 4(10). 964–968. 170 indexed citations

2.

Bezerra, G.A., E. Dobrovetsky, Aiping Dong, et al.. (2012). Structures of Human DPP7 Reveal the Molecular Basis of Specific Inhibition and the Architectural Diversity of Proline-Specific Peptidases. PLoS ONE. 7(8). e43019–e43019. 25 indexed citations

3.

Haffner, Curt D., Aaron B. Miller, Robert A. Reid, et al.. (2008). Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP). Bioorganic & Medicinal Chemistry Letters. 18(15). 4360–4363. 47 indexed citations

4.

Baker, K.D., Lisa M. Shewchuk, Tatiana Kozlova, et al.. (2003). The Drosophila Orphan Nuclear Receptor DHR38 Mediates an Atypical Ecdysteroid Signaling Pathway. Cell. 113(6). 731–742. 182 indexed citations

5.

Catalano, John G., David N. Deaton, Eric S. Furfine, et al.. (2003). Exploration of the P1 SAR of aldehyde cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(1). 275–278. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact